Progress on biomarkers of Mycoplasma pneumoniae pneumonia
10.3760/cma.j.issn.1673-4408.2023.06.006
- VernacularTitle:肺炎支原体肺炎生物标志物的研究进展
- Author:
Xue ZHANG
1
;
Wanyu JIA
;
Peng LI
;
Chunlan SONG
Author Information
1. 郑州大学附属儿童医院 河南省儿童医院 郑州儿童医院南院区急诊科 450052
- Keywords:
Mycoplasma pneumoniae pneumonia;
Biomarkers;
Diagnosis
- From:
International Journal of Pediatrics
2023;50(6):383-387
- CountryChina
- Language:Chinese
-
Abstract:
Mycoplasma pneumoniae pneumonia is an important component of community-acquired pneumonia, which can cause severe extrapulmonary complications of digestive, cardiovascular, blood, urinary and other systems.Accurate and effective biomarkers are significant for the diagnosis and treatment of Mycoplasma pneumoniae pneumonia.Recent studies have shown that new biomarkers such as IL-35, IL-17, neutrophil to lymphocyte ratio(NLR) and S100 protein are involved in the development of Mycoplasma pneumoniae pneumonia.In order to provide reference for the clinical diagnosis and treatment of Mycoplasma pneumoniae pneumonia, this paper reviews the progress of new biomarkers in Mycoplasma pneumoniae pneumonia.
